Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (321-330 of 426) with videos related to

Pageof 43
Sort By:
Rheumatology (Oxford, England)|May 7, 2016
Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic explorationDorota M Rowczenio, Daniela S Iancu, Hadija Trojer, et al.
British Journal of Haematology|June 30, 2021
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal dataSriram Ravichandran, Oliver C Cohen, Steven Law, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A DeletionDorota M Rowczenio, Hadija Trojer, Ebun Omoyinmi, et al.
Blood Cancer Journal|June 22, 2021
Impact of early response on outcomes in AL amyloidosis following treatment with frontline BortezomibSriram Ravichandran, Oliver C Cohen, Steven Law, et al.
British Journal of Haematology|January 13, 2010
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisJulian D Gillmore, Glenys A Tennent, Winston L Hutchinson, et al.
European Journal of Haematology|June 5, 2020
The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosisOliver C Cohen, Faye Sharpley, Janet A Gilbertson, et al.
European Heart Journal. Cardiovascular Imaging|June 19, 2014
Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosisDavid F Hutt, Anne-Marie Quigley, Joanne Page, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 22, 2012
Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundanceJ H Pinney, H J Lachmann, P T Sattianayagam, et al.
The Journal of Pathology. Clinical Research|February 12, 2019
The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosisTamer Rezk, Janet A Gilbertson, P Patrizia Mangione, et al.
JACC. Cardiovascular Imaging|January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosisJason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
Pageof 43

Showing results (321-330 of 426) with videos related to

Sort By:
Pageof 43
Rheumatology (Oxford, England)|May 7, 2016
Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic explorationDorota M Rowczenio, Daniela S Iancu, Hadija Trojer, et al.
British Journal of Haematology|June 30, 2021
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal dataSriram Ravichandran, Oliver C Cohen, Steven Law, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A DeletionDorota M Rowczenio, Hadija Trojer, Ebun Omoyinmi, et al.
Blood Cancer Journal|June 22, 2021
Impact of early response on outcomes in AL amyloidosis following treatment with frontline BortezomibSriram Ravichandran, Oliver C Cohen, Steven Law, et al.
British Journal of Haematology|January 13, 2010
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisJulian D Gillmore, Glenys A Tennent, Winston L Hutchinson, et al.
European Journal of Haematology|June 5, 2020
The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosisOliver C Cohen, Faye Sharpley, Janet A Gilbertson, et al.
European Heart Journal. Cardiovascular Imaging|June 19, 2014
Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosisDavid F Hutt, Anne-Marie Quigley, Joanne Page, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 22, 2012
Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundanceJ H Pinney, H J Lachmann, P T Sattianayagam, et al.
The Journal of Pathology. Clinical Research|February 12, 2019
The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosisTamer Rezk, Janet A Gilbertson, P Patrizia Mangione, et al.
JACC. Cardiovascular Imaging|January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosisJason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
Pageof 43